- Exchange: Stockholm
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Instruments
Snapshot for Getinge AB (GETIB)
| Open: | 199.000 | Day's Range: | 197.700 - 199.400 | Volume: | 385,379 |
|---|---|---|---|---|---|
| Previous Close: | 199.500 | 52wk Range: | 165.400 - 225.100 | 1-Yr Rtn: | +15.32% |
Key Statistics for GETIB
| Current P/E Ratio (ttm) | 20.8063 |
|---|---|
| Estimated P/E(12/2013) | 16.8441 |
| Relative P/E vs. OMX | 1.2818 |
| Earnings Per Share (SEK) (ttm) | 9.5836 |
| Est. EPS (SEK) (12/2013) | 11.8380 |
| Est. PEG Ratio | 1.4397 |
| Market Cap (M SEK) | 47,521.68 |
| Shares Outstanding (M) | 222.38 |
| 30 Day Average Volume | 592,182 |
| Price/Book (mrq) | 3.1639 |
| Price/Sale (ttm) | 1.9266 |
| Dividend Indicated Gross Yield | 2.08% |
| Cash Dividend (SEK) | 4.1500 |
| Last Dividend | 03/22/2013 |
| 5 Year Dividend Growth | 12.00% |
| Next Earnings Announcement | 07/11/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GETIB
Company Profile & Key Executives for GETIB
Getinge AB develops, manufactures, and sells equipment and systems for sterilization and disinfection. The Company markets to the pharmaceutical industry, hospitals, dental clinics, and laboratories. Getinge produces in the United Kingdom, France, the United States, and Australia. The products are sold by subsidiaries, sales offices, and distributors worldwide.
| Carl BennetChairman | Johan MalmquistPresident/CEO |
| Ulf GrunanderChief Financial Officer | Heinz JacquiExec VP:Medical Systems |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
GETIB News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page